TrialMolecular cancer2025

Anlotinib combined with benmelstobart as a chemo-free first-line treatment in advanced esophageal squamous cell carcinoma: an exploratory multicenter, single-arm phase II clinical trial.

Xiangrui Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.